Norma Group Se · XETR:NOEJ

Norma — Norma Group Ag Name Akt — Q2 2020 Earnings Presentation

83 slides from Norma's earnings presentation, Aug 5, 2020

  1. Slide 1: NORMA Group SE Second Quarter 2020 Results

    NORMA Group SE Second Quarter 2020 Results 1

  2. Slide 2: Agenda

    Facts & Figures Q2 2020 p. 3 Top Line, P&L & Segment Reporting p. 4-9 (Net) Debt & Maturity Profile p. 10-11 Cash Flow and NOVA p. 12-13 Outlook and Guidance p. 14-16 Appendix: FY 2019 p. 17-53 Business Modell, Track Record & CSR p. 54-78 Share Information and others p. 79-83 2

  3. Slide 3: Q2 2020 Facts & Figures highlights

    Sales Sales down by -33.8% to EUR 191.5 million (Q2 2019: EUR 289.0 million) Adjusted EBITA Adjusted EBITA at EUR -22.5 million (Q2 2019: EUR 40.9 million), including EUR 21.5 million costs (margin) related to the change program „Get on Track“; margin of -11.8% (Q2 2019: 14.2%) Adjusted EBIT Adjuste

  4. Slide 4: Sales development

    Thereof Thereof Sales 2019 2020 Change Change in % organic currency Q1 275.6 253.6 -22.0 -8.0% -8.9% 0.9% Q2 289.0 191.5 -97.6 -33.8% -33.9% 0.1% H1 564.7 445.0 -119.6 -21.2% -21.7% 0.5% • Organic decline of 33.9% in Q2 2020 resulting from 15% 600 − a weak EJT and DS business in all (13%) 79 -123 3

  5. Slide 5: Regional sales: EMEA, Americas, APAC

    EMEA • EJT: production reductions following the EMEA AM APAC EMEA AM APAC shutdowns at European OEMs due to the 200 3.1 COVID-19 pandemic lead to an organic decline 0 of 29.4% in H1 2020 (Q2 2020: -52.6%) Q2 2019 -0.8 -3.2 -2.7 Q2 2019 • DS: organic decline of 19.2% in H1 2020 (Q2 -20 -37.9 2020: -2

  6. Slide 6: EBITA margin influenced by Get on Track costs

    • EBITA margin highly influenced by costs related to the change program „Get on Track“ • EBITA margin excl. costs related to the change program „Get on Track“ at 5.9% in H1 2020 • EBITDA margin excl. costs related to the change program „Get on Track“ at 10.8% in H1 2020 EUR million 200 20.1% 20.0% 2

  7. Slide 7: Gross profit margin and cost ratios

    • Gross profit margin decreased in Q2 2020 compared to Q2 2019 mainly due to higher destocking; Material cost ratio stable • Personnel expenses ratio increased in Q2 (44.6%) compared to Q1 (30.3%) mainly due to costs related to the change program „Get on Track” • Other operating income and expenses

  8. Slide 8: Adjusted versus reported earnings H1 2020

    • No adjustment of costs related to the change program „Get on Track“ leading to the same reported and adjusted EBITDA • EUR 22.1 million costs related to the change program „Get on Track“ in H1 2020 are not shown on an adjusted basis • PPA adjustments of EUR 12.8 million on EBIT level • Total adjus

  9. Slide 9: Adjusted and reported EPS

    • Adjusted and reported EPS negatively impacted by the COVID-19 pandemic and costs related to the change program „Get on Track“ • Dividend of EUR 0.04 per share approved by virtual AGM on June 30, 2020 EUR EUR EUR 2 2 1,2 1 1 0,8 0.81 1.10 0.49 0 0 0,4 -0.72 -0.87 0.04 -1 -1 0,0 Q2 2019 Q2 2020 Q2 2

  10. Slide 10: Equity ratio, net debt and leverage

    • Equity Ratio of 40.9% (Dec. 31, 2019: 41.6%) with a slight decline due to a negative net profit and dividend payment • Leverage increases to 3.7 due to lower EBITDA while net debt decreases by 1.5% to EUR 414 million compared to year end 2019, due to strict cash management • Leverage excluding the

  11. Slide 11: Maturity profile

    300 45 EUR 15 million 200 already prolonged 248 100 15 65 EUR 29 million 42 already repayed 29 35 21 42 0 2020 2021 2022 2023 2024 2025 2026 Bank Borrowings Promissory Note 1 Promissory Note 2 Promissory Note 3 CP Program • Solid long-term maturity profile • No covenant breach possible at least unti

  12. Slide 12: Net operating cash flow

    in EUR million Q2 2019 Q2 2020 Variance* H1 2019 H1 2020 Variance* (Adjusted) EBITDA 51.6 -11.7 -122.7% 101.3 26.5 -73.8% Δ ± Trade Working capital -10.5 20.6 +296.2% -48.6 -3.6 -92.6% Net operating cash flow before investments 41.1 8.9 -78.4% 52.7 22.9 -56.6% from operating business Δ ± Investments

  13. Slide 13: NORMA Value Added (NOVA)

    in EUR million Q2 2019 Q2 2020 H1 2019 H1 2020 Adjusted EBIT after taxes 28.3 -19.5 56.2 0.5 Capital Cost (WACC x CE per January 1st) -17.7 -20.8 -35.2 -41.2 NOVA 10.5 -40.3 21.1 -40.7 • NORMA Group determines the annual value creation in form of the so-called NORMA Value Added (NOVA) • NOVA is NORM

  14. Slide 14: Get on Track program accelerated

    • “Get on Track” program accelerated also due to COVID-19 pandemic • EUR 21.5 million costs in Q2 2020 related to location projects lead to increased costs in 2020 of EUR 30 million • First benefits include improvements in purchasing and product portfolio 2020 2021 2022 2023 2024 ongoing 60 ~50 ~50

  15. Slide 15: Guidance 2020 not yet possible

    • Impact of the COVID-19 pandemic cannot be reliably estimated by the time of the publication of the Q2 2020 results • Guidance for fiscal year 2020 due to the current market conditions not yet possible 15

  16. Slide 16: COVID-19 impacts and measures

    Coronavirus Uncertainty regarding potentially upcoming second Market Ongoing monitoring of COVID-19 development and (COVID-19) wave of the COVID-19 pandemic Situation market demand situation Weak sector due to global economic situation and Automotive upcoming powertrain technologies as well as Ongoi

  17. Slide 17: Appendix

    /aNSEBA Appendix

  18. Slide 18: Appendix agenda

    Facts & Figures Full Year 2019 p. 19-21 Segments and P&L Statement p. 22-35 Balance Sheet Development p. 36-41 Cash Flow and NOVA p. 42-44 Outlook and Guidance p. 45-53 Business Model and Track Record p. 54-74 Corporate Responsibility p. 75-78 Share Information p. 79-83 18

  19. Slide 19: Facts & Figures FY 2019

    Facts & Figures FY 2019

  20. Slide 20: FY 2019 key figures

    Sales Sales at EUR 1,100.1 million (2018: EUR 1,084.1 million); growth of 1.5% Organic Organic decline of -2.0% in 2019 (2018: +7.7%) revenue Adjusted Adjusted EBITA at EUR 144.8 million (2018: EUR 173.2 million) EBITA Margin Adjusted EBITA margin at 13.2% (2018: 16.0%) Adjusted EPS at EUR 2.76 (201

  21. Slide 21: FY 2019 balance sheet and cash flow highlights

    Strong balance sheet with an equity ratio of 41.6% (2018: 40.9%) despite dividend payments and higher Equity balance sheet total Net debt increased to EUR 420.8 million (2018: EUR 400.3 million) including dividend payments and Net Debt IFRS16 Leverage Net debt / adj. EBITDA leverage increased to 2.2

  22. Slide 22: Profit & Loss, Segment Reporting

    Profit & Loss, Segment Reporting

  23. Slide 23: Sales 2019 by quarter

    thereof thereof thereof Sales 2018 2019 Change Change in % organic acquisitions currency Q1 272.6 275.6 + 3.0 + 1.1% - 4.2% + 2.3% + 3.1% Q2 276.4 289.0 + 12.6 + 4.6% - 0.4% + 2.4% + 2.5% Q3 268.1 274.0 + 5.9 + 2.2% - 0.1% + 0.2% + 2.1% Q4 267.0 261.4 - 5.6 - 2.1% - 3.3% 0.0% + 1.2% FY 1,084.1 1,100

  24. Slide 24: Sales history and CAGR

    CAGR ~ 9% 1200 2011 65.6 13.4% 1000 2012 -10.8 -1.9% 2013 15.1 2.5% 800 2014 41.3 6.5% 600 2015 25.9 3.7% 1,084 1,100 1,017 2016 7.6 0.9% 890 895 400 695 2017 77.0 8.6% 605 636 581 458 490 2018 78.6 7.7% 200 385 330 2019 -21.6 -2.0% 0 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019

  25. Slide 25: EMEA sales 2019

    • Weak automotive sector led to decline in EJT of -2.4%, 500 20 3% 2.0% while DS was also trending down in Q4 with -1.9% for the 400 2% full year 10 9.5 1% 300 • 495 0 0% 486 200 -11.4 -1% Acquisition of Statek had a positive impact of EUR 3 million -10 or 0.6% on group sales 100 -2% -20 -2.3% -3% •

  26. Slide 26: Americas sales 2019

    • 500 60 12.4% 15% Strong organic growth of NDS was more than offset by strong organic decline of EJT business (especially in Q4) 400 40 10% caused by strikes and weak automotive business 300 51.2 • 20 5% 200 442 451 0 0% No M&A effects in the Americas in 2019 100 -13.6 • -20 -3.1% -5% 0 2018 2019 E

  27. Slide 27: Asia-Pacific sales 2019

    • Despite a very weak Chinese market, EJT grow moderately 200 20 20% with a very good recovery in Q4. DS with a slightly positive 14.9% organic growth, resulting for the region in an overall 150 15 15% moderate organic growth of 2.3% 10 10% • 100 148 163 The acquisition of Kimplas had a positive eff

  28. Slide 28: Sales split EJT and DS

    thereof water management thereof industrial supplier 20% (17%) 32% (33%) DS EJT = Engineered Joing Technology 39% (37%) DS = Distribution Services EJT 61% (63%) 19% (20%) thereof general distribution products 9% (10%) thereof 20% commercial vehicle OEM (20%) thereof passenger vehicle OEM * FY 2019 (

  29. Slide 29: Cost ratios 2019

    • Material costs ratio improved by 20 BP with stabilizing raw material prices and lower changes in inventories compared to prior year • Personnel cost ratio higher at 27.5% (2018: 25.9%) due to payments for a former board member and prior years’ bonus provision release • Other operating income and e

  30. Slide 30: Margin development

    20% 17.4% 17.7% 17.4% 17.7% 17.5% 17.6% 17.6% 17.2% 16.0% 16% 16.5% 17.1% 16.8% 16.9% 16.5% 16.7% 16.6% 16.3% 13.2% 14.4% 15.2% 12% 12.4% 13.6% 8% 4% 10.7% 0% 9.9% -4% 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 H1 2019 H1 2020 EBITDA adjusted EBITDA reported EBITA adjusted EBITA reported EBIT

  31. Slide 31: Adjustments history

    + Acquisition and Rightsizing Costs* 17.5 16.8 0 0 6.9 3.6 4.8 3.5 4.4 13.4 + PPA Depreciation 3.0 1.2 0.3 0.5 1.3 2.2 2.3 4.2 4.0 3.5 Total Adjustments 20.5 18.0 0.3 0.5 8.2 5.8 7.1 7.7 8.4 16.9 + Acquisition and Rightsizing Costs* 17.5 16.8 0 0 6.9 3.6 4.8 3.5 4.4 13.4 + PPA Depreciation 3.0 1.2 0

  32. Slide 32: Adjusted to reported earnings 2019

    • Operational adjustments on EBITDA level mainly due to the rightsizing program • Additional PPA adjustments of EUR 26 million on EBIT level from past acquisitions • Total adjustments per share of EUR 0.93 Sales 1,100.1 1,100.1 EBITDA 173.8 13.4 187.2 (incl. EUR 0.4 million integration costs and EUR

  33. Slide 33: Expected adjustments

    • Costs for “Get on Track” change program will not be adjusted • Ongoing PPA adjustments slightly decreasing over time • Adjustments on EPS level declining in the upcoming years** 13.4 EBITDA level (incl. EUR 0.4 million integration costs and EUR 13.1 0 0 million Rightsizing costs) 16.9 ca. 3 ca. 2

  34. Slide 34: Adjusted and reported EPS

    EUR EUR 4 4 3 3 2 2 3.61 2.76 2.88 1 1 1.83 0 0 2018 2019 2018 2019 34

  35. Slide 35: Income statement

    Sales 1,084.1 1,100.1 1,084.1 1,100.1 Gross Profit 626.6 630.6 626.2 630.4 EBITDA 201.4 187.2 197.0 173.8 in % of sales 18.6% 17.0% 18.2% 15.8% EBITA 173.2 144.8 164.8 127.9 in % of sales 16.0% 13.2% 15.2% 11.6% EBIT 164.5 136.1 133.5 96.7 in % of sales 15.2% 12.4% 12.3% 8.8% Financial Result -11.7

  36. Slide 36: Balance Sheet and Maturity Profile

    Balance Sheet and Maturity Profile L.

  37. Slide 37: Working capital development

    EUR million 400 18.1% 18.3% 18.5% 18.1**% 20% 17.4% 17.1% 17.5% 16.1% 16.5% 15.6% 300 143 14.8% 162 15% 15.0% 153 13.2% 200 13.8% 123 13.9% 124 15.5% 108 13.9% 81 13.1% 79 14.2% 90 100 14.3% 70 178 173 10% 11.5% 12.6% 16.5% 115 14.6% 130 15.6% 140 14.9% 151 16.4% 15.7% 13.2% 12.3% 80 65 67 74 0 -6.3

  38. Slide 38: Equity development

    • Equity increased by EUR 27 million with profit of EUR 58 million • Dividend payment in 2019 for 2018 of EUR 35 million EUR million 700 -35 6* 600 58 500 400 300 600** 629 200 100 0 Equity 2018 Profit Dividend Others* Equity 2019 * mainly exchange differences on translation of foreign operations of

  39. Slide 39: Leverage and net debt

    • Leverage increases to 2.2 (2018: 1.9) and net debt increases by 5.1% to EUR 421 million including dividend payment of EUR 35 million an EUR 39 million due to IFRS 16 in EUR million 400 421 600 (Net debt / 1.9 x adjusted EBITDA) 400 590 (Net debt / equity) 0.7 x 601 200 0 -190 -180 -200 Dec 31, 201

  40. Slide 40: Debt maturity profile and currencies

    400 Bank Borrowings Promissory Note 1 Promissory Note 2 Promissory Note 3 CP Program 300 45 200 100 248 15 65 42 0 29 35 21 42 2020 2021 2022 2023 2024 2025 2026 400 USD 300 EUR 109 200 100 12 184 51 44 49 52 41 0 2020 2021 2022 2023 2024 2025 2026 40

  41. Slide 41: Balance sheet items

    Goodwill / Other intangible assets Total equity 602.5 916.2 / Property, plant & equipment Other non-financial assets / Derivative financial assets / 12.1 Retirement benefit obligations / Deferred- and income tax assets 28.8 Provisions Total non-current assets 928.3 Borrowings and 589.9 other financi

  42. Slide 42: Cash Flow & NORMA Value Added

    Cash Flow & NORMA Value Added

  43. Slide 43: Net operating cash flow 2019

    Adjusted EBITDA 117.0 120.8 129.3 138.4 177.5 179.4 199.7 201.4 187.2 -7.1% Δ ± Trade Working capital -19.5 -9.8 +5.1 +10.4 -0.6 +17.0 -19.1 -13.7 -9.5 -30.7% 97.5 111.0 134.4 148.8 176.9 196.4 180.6 187.7 -5.3% Δ ± Investments from operating -30.7 -30.0 -30.5 -39.6 -42.2 -47.9 -47.7 -63.3 -54.8 -13

  44. Slide 44: NOVA and ROCE

    • The NORMA Value Added (NOVA) is NORMA Group‘s long term strategic target Adjusted EBIT after taxes 123.5 98.4 • NORMA Group determines the annual value • creation in form of the so called NORMA Value Added Capital Cost (WACC x CE per January 1st) -62.8 -81.1 (NOVA) • NOVA is calculated on the basi

  45. Slide 45: Outlook and Guidance

    Outlook and Guidance

  46. Slide 46: Rightsizing program

    Optimization of the production landscape, which has grown rapidly as a result of acquisitions, organizational structures and further harmonization of processes and systems worldwide The optimization measures have been extended across all regions and also supraregional Further development of the busi

  47. Slide 47: Get on Track change program

    Change program will set basis for further strategic development and profitable growth of NORMA Group Key objective to return NORMA to historic profit margin levels Start execution of holistic performance program to increase efficiency and achieve full profit potential across NORMA Group Alignment of

  48. Slide 48: Get on Track measures

    • Increase share of best cost country production • Reduction of complexity • Streamlining of product portfolio through active portfolio management • Bundle and transfer low volume products and business to wholesaler • Strengthen commodities strategy • Focus on best cost country purchasing • Improvem

  49. Slide 49: Program cost volume

    In EUR million 50 • Accumulated total cost 5 volume for implementation of around EUR 55 million until 2023. 25 • Implementation costs will be shown on an unadjusted basis. 20 Locations Structures & Processes Product Portfolio 49

  50. Slide 50: Get on Track costs and benefits

    • “Get on Track” program accelerated also due to COVID-19 pandemic • EUR 21.5 million costs in Q2 2020 related to location projects lead to increased costs in 2020 of EUR 30 million • First benefits include improvements in purchasing and product portfolio 2020 2021 2022 2023 2024 ongoing 60 ~50 ~50

  51. Slide 51: Strategic priorities

    Execution of rightsizing- and “Get on Track”-projects as a foundation of further profitable 1 growth 2 Expanding water business 3 Continue to develop product and service solutions for Continue to explore business opportunities particularly in Asia-Pacific to expand localization 4 and further improve

  52. Slide 52: Guidance 2020 financial targets

    Noticeable organic decline of around – 2% to – 4% Negative impact expected More than 13% Negative impact expected More than 12% Negative impact expected Roughly at the same level as in the previous year Currently unknown Roughly at the same level as in the previous year Currently unknown Up to EUR -

  53. Slide 53: Guidance 2020 non-financial targets

    Around 5% of EJT sales Currently unknown More than 20 invention applications No impact expected Proportion of defective parts in production to be below the No impact expected value of 20 parts per million Number of quality-related customer complaints per month to No impact expected be below 8 Operat

  54. Slide 54: Business Model and Track Record

    Business Model and Track Record

  55. Slide 55: Global market and technology leader in joining and fluid handling

    Global market and Offers more than 40,000 technology leader in joining NORMAFLUID ® innovative joining solutions in Delivers to more than and fluid handling 42% product categories: three 10,000 customers in 100 technology. Water, Fluid, Fasten. countries. NORMACONNECT ® Operates a global network 32%

  56. Slide 56: Engineered Joining Technology in attractive markets

    Engineered Joining Technology in the attractive markets water management, e-mobility and general industry Strong development and growth opportunities in water management and e-mobility Enhanced stability through broad diversification across products, end markets and regions Engineered products with

  57. Slide 57: Customer benefits of NORMA products

    • Continuous new developments on a • Superior service level through global level in order to fulfill fleet worldwide presence and regional consumption regulations and cope sales hubs. with increased awareness in public perception. • Comprehensive customized • Ongoing trend in many product portfolio:

  58. Slide 58: Asia-Pacific and water business expansion

    • 20% of sales or EUR 218.1 million in 2019 • Production and distribution sites in Australia, Malaysia, the US and India • Expanding Water Business organically and through M&A transactions Acq.: Chien Jin Plastic (MYS) Acq.: Guyco (AUS) Acq.: NDS (USA) Acq.: Kimplas (IND) Acq.: Davydick & Co (AUS) →

  59. Slide 59: NDS product segments

    Efficient Landscape Irrigation ca. 27% Stormwater Management ca. 61% Flow Management and Others ca. 12% 59

  60. Slide 60: NDS wholesale and retail customers

    • More than 4,950 products • Over 15,800 customer locations (retail and wholesale customers) • Three production sites (CA), six warehouses in the US, more than 500 employees • Orders received by 11 am are shipped the same day for wholesale orders • 97% order fill rate, 98% on-time shipment of orders

  61. Slide 61: Water management market

    Watermanagement Market for Joining and Fluid Handling Technology Stormwater Management Efficient Landscape Irrigation Flow Management and Others 61

  62. Slide 62: E-mobility growth perspectives

    Battery Thermal Management Growth Coolant Systems perspec- tives Power Electronics and Motors Cooling HVAC / Heat Pump Systems Combustion engine Thermal applications management Battery New applications battery engine Cooling Production volume in million System / HVAC 120 Thermal Engine Engine manage

  63. Slide 63: Tightening emission regulations

    • Environmental awareness continues to drive tightening emission regulations globally, including in emerging markets • Low-emission alternatives require significantly higher joining technology content at a substantially increased complexity compared to existing/past technologies 63

  64. Slide 64: Two distinct ways to market

    High quality, branded and standardized Innovation and product solution partner for joining products provided at competitive customers, focused on engineering prices to broad range of customers. expertise with high value-add. Unique business model with two distinct ways-to-market • Significant econom

  65. Slide 65: Market growth and competitors

    Sales in EUR million (year)* 1200 Additional growth for Joining Technology 1,100 market above market growth 1000 ca. Water ( ca. 20%) / Fluid ( ca. 30%) 800 50% Passenger vehicles 600 Commercial vehicles ca. Fasten 50% 360 400 Agricultural equipment 200 Add. 2-4% 65 64 60 36 30 24 21 Construction eq

  66. Slide 66: Basis for premium pricing

    Basis for premium pricing Market leadership Technology Quality Innovation Tailor-made solutions ca. EUR 224 content per vehicle in total ca. EUR 95 in other application areas < 0.1% content per vehicle ca. EUR 350,000 ca. EUR 24 ca. EUR 82 costs an average ca. EUR 23 in the cooling in the exhaust ha

  67. Slide 67: Products, end markets and customers

    Construction / Construction Engines Commercial vehicles infrastructure / water Passenger vehicles equipment management Wholesalers & Agricultural equipment Shipbuilding HVAC Pharma & Biotech technical distributors • More than 40,000 products, manufactured in 28 locations and sold to more than 10,000

  68. Slide 68: Quality risks

    • Reputation loss • Image loss • Warranty costs • Non-compliance with legal requirements/regulations 68

  69. Slide 69: Company history and acquisitions

    Acquisition Acquisition 2018 Kimplas, India Statek, Germany Acquisition Acquisition 2017 Lifial, Portugal Fengfan, China Acquisition 2016 Autoline Business, France Foundation Acquisition Acquisition National 2014 NORMA China II Five Star, USA Diversified Sales, USA 2011 Acquisition Acquisition Varia

  70. Slide 70: Acquisition track record

    CONNECTORS Verbindungstechnik AG, Switzerland 04/12 Market entry in connecting technology in Pharma & Biotech 16.6 Nordic Metalblok S.r.l., Italy 07/12 Market consolidation heating and air conditioning clamps 5.2 Chien Jin Plastic Sdn. Bhd., Malaysia 11/12 Market entry joining elements for water dis

  71. Slide 71: Global footprint

    EMEA Czech Republic (P) France (P, D) Germany (P, D) Italy (D) Netherlands (D) Poland (P, D) Portugal (P) Russia (D) Serbia (P) Spain (D) Sweden (P, D) Switzerland (P, D) Turkey (D) United Kingdom (P, D) Americas Brazil (P, D) Mexico (P, D) USA (P, D) Asia-Pacific Australia (D) China (P, D) India (P

  72. Slide 72: Management Board

    Chairman of the Management Board, Member of the Management Board, CEO and CFO ad interim of NORMA Group SE COO of NORMA Group SE since November 14, 2019 since October 1, 2018 Responsibilities: Responsibilities: Group Development, Group Communications, Sales, Product Development, R&D, Divisional Deve

  73. Slide 73: Long-term cost and margin development

    of sales 1200 700 65% 61.0% 59.1% 57.8% 57.3% 59.9% 600 58.4% 58.4% 57.0% 60% 900 500 54.9% 55.3% 56.0% 55.5% 400 55% 600 1,084 1,100 1,017 300 601 627 631 890 895 533 546 50% 636 695 200 406 300 581 605 323 344 371 458 490 251 275 45% 330 100 182 0 0 40% 2008 2009 2010 2011 2012 2013 2014 2015 2016

  74. Slide 74: Working capital and capex history

    EUR million EUR million 160 of sales 400 18.1% 18.3% 18.5% 17.4% 18.1% 17.1% 17.5% 20% 140 16.1% 15.6% 16.5% 120 162 15% 153 143 100 200 123 124 108 80 70 81 79 90 10% 149 130 140 151 178 173 135 133 65 67 74 80 115 60 124 123 0 104 109 -46 -41 -38 -59 -81 -101 -120 5% 40 81 -146 -142 -143 67 62 67

  75. Slide 75: Corporate Responsibility

    [oNSER Corporate @ Responsibility US7

  76. Slide 76: CR policy topics

    Find all details in • Compliance NORMA Group’s CR • Anti-Discrimination Policy • Freedom of Association • Awareness of CR • Health & Safety • NORMA Clean Water • Training & Development • NORMA Help Day • Remuneration & Employee • Donations & Sponsoring Satisfaction • Diversity • Climate • Quality •

  77. Slide 77: UN Global Compact and CR governance

    Membership with UN Global Compact • Ten principles in the areas of human rights, labor, the environment and anti-corruption Management Board Human and Labor Rights • “NORMA Group categorically rejects and does not accept any form of violation of human rights.” Corporate Responsibility Signatory of D

  78. Slide 78: Approach to sustainability

    NORMA Group’s approach to sustainability / corporate responsibility [a Stakeholder communication (onson* TIE — CHANGING management E=] vY audited

  79. Slide 79: Share & Shareholders

    Share & Shareholders

  80. Slide 80: Shareholder structure

    Allianz Global Investors GmbH, Frankfurt am Main, Germany 15.20% Ameriprise Financial Inc., Wilmington, DE, USA 6.74% 33% Impax Asset Management Group Plc, London, United Kingdom 5.08% 14% T. Rowe Price Group, Inc.., Baltimore, Maryland, US 5.01% Threadneedle Management Luxembourg S.A. 4.90% 8% Mini

  81. Slide 81: Share price performance

    60 40 20 0 -20 -40 -60 -80 Dez. 18 Mrz. 19 Jun. 19 Sep. 19 Dez. 19 Mrz. 20 Jun. 20 NORMA Group DAX MDAX SDAX MSCI World Automobil 81

  82. Slide 82: Financial calendar and contact

    Publication of Interim Results Q3 2020 November 4, 2020 Publication of Full Year 2020 Results March 24, 2021 Publication of Interim Results Q1 2021 May 5, 2021 Annual General Meeting May 20, 2021 Publication of Interim Results Q2 2021 August 4, 2021 Publication of Interim Results Q3 2021 November 3,

  83. Slide 83: Forward-looking statements disclaimer

    This presentation contains certain future-oriented statements. Future-oriented statements include all statements which do not relate to historical facts and events and contain future-oriented expressions such as ‘believe,’ ‘estimate,’ ‘assume,’ ‘expect,’ ‘forecast,’ ‘intend,’ ‘could’ or ‘should’ or

Norma Group Ag Name Akt — Q2 2020 Earnings Presentation on 6ix